Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy
- 5 Downloads
We sought to develop a nomogram for the prediction of tumor recurrence after resection of hepatocellular carcinoma (HCC) within the Milan criteria.
Consecutive HCC patients admitted for hepatectomy between 1994 and 2014 were enrolled in this study. Patients were excluded if they had recurrent HCC or tumors beyond the Milan criteria. Patients were randomized and assigned to the derivation and validation sets in a 1:1 ratio. Independent factors for disease-free survival were identified using the Cox regression model. A nomogram was derived and validated with the receiver-operating characteristic (ROC) and calibration curves.
There were 617 eligible patients included in the analysis. The median age was 59 years, 481 were male, and 87.8% of the patients were hepatitis B virus carriers. The median follow-up was 68.7 months. The 5-year overall survival rate was 73.3% and HCC recurrence was detected in 55% of the patients. In the derivation set, a nomogram was constructed based on the seven independent factors for disease-free survival: age, alpha-fetoprotein, preoperative prothrombin time, magnitude of hepatectomy, postoperative complication, number of tumor nodules, and presence of microvascular invasion. A satisfactory discrimination ability was observed in both the derivation and validation sets (c-stat 0.672 and 0.665, respectively). The calibration plot yielded agreement between the predicted and observed outcomes, using the derived nomogram.
A validated nomogram quantifies the risk of recurrence after hepatectomy for HCC within the Milan criteria, and assists with the planning of individual postoperative surveillance protocols.
KeywordsHepatocellullar carconoma Recurrence Prediction Nomogram
Natural log of AFP
Associating liver partition with portal vein ligation for staged hepatectomy
Area under curve
Clinical risk score
Cavitron ultrasonic surgical aspirator
Estimated standard liver volume
The University of Hong Kong
International normalization ratio
Protein-induced vitamin K antagonist II
We thank Mr. Yuen Ho Kam, Kim Bsc (Comp&stat) for data management and analysis.
This study received no support in the form of equipment, drugs, grants or funding.
Compliance with ethical standards
Conflict of interest
We have no conflicts of interest to declare in relation to this study.
- 1.El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002;35(5):72-S8.Google Scholar
- 14.Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240(4):698–708 (discussion—10).PubMedPubMedCentralGoogle Scholar
- 15.Cheung TT, Chan SC, Chok KS, Chan AC, Yu WC, Poon RT, et al. Rapid measurement of indocyanine green retention by pulse spectrophotometry: a validation study in 70 patients with Child-Pugh A cirrhosis before hepatectomy for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2012;11(3):267–71.CrossRefGoogle Scholar
- 29.Motoyama H, Kobayashi A, Yokoyama T, Shimizu A, Sakai H, Furusawa N, et al. Impact of advanced age on the short-and long-term outcomes in patients undergoing hepatectomy for hepatocellular carcinoma: a single-center analysis over a 20-year period. Am J Surg. 2015;209(4):733–41.CrossRefGoogle Scholar
- 32.Liu P-H, Hsu C-Y, Lee Y-H, Hsia C-Y, Huang Y-H, Su C-W, et al. Uncompromised treatment efficacy in elderly patients with hepatocellular carcinoma: a propensity score analysis. Medicine. 2014;93(28).Google Scholar